---
$id: https://graph.org.ai/products/commodity/51111757
$type: Product
source: UNSPSC
code: "51111757"
title: "Teloxantrone"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Teloxantrone

**UNSPSC Code**: 51111757
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthrapyrazole antibiotic with the molecular formula C21H25N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 96521WL61B, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino)- but generally known as teloxantrone, which bears US NIH Compound Identifier 5364123. European Medicines Agency schedules Teloxantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10875MIG. The term TELOXANTRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). TELOXANTRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule teloxantrone under HS 29339990 and SITC 51577. As of Q4 2014, TELOXANTRONE remains the US FDA Preferred Term for this commodity. Teloxantrone bears US NLM identifiers UMLS ID C0244823 and NCI Concept Code C1520. SMILES: OC1C2C3C([NH]N(C3CCC2NCCNC)CCNCCO)C2C1C(=O)C=CC2=O.

